Merck Uses Deception to Increase Sales of Vioxx
A newly released report claims that pharmaceutical company Merck engaged in various forms of scientific deception to downplay risks of the painkiller Vioxx and promote the drug’s sale. Merck disguised in-house studies to appear to have been conducted by independent scientists at medical schools, according to a report published in the Journal of the American Medical Association. Information for the report was gathered using thousands of documents uncovered during Vioxx-related lawsuits.